🟢 Nasus Pharma is trading 6.16% up today with no identified company-specific catalyst

Nasus Pharma is trading 6.16% higher at $3.79, with no reliable company-specific announcement identified to explain the gain.

• No reliable announcement dated September 23, 2026, has been identified; available coverage points to routine trading activity.
• The latest identifiable catalyst was September 14 FDA clearance for its NS002 clinical study.
• Broader markets are lower, so macro sentiment does not clearly explain the gain.